USPTO 2015–2025 USPTO PatentsView US Corporation

Pulse, LLC

USPTO PatentsView assignee record - 11 granted patents across 8 technology areas, recorded in grant years 2016–2024. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61N (ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy).

RSS updates for this company

The verdict

According to USPTO PatentsView, Pulse ranks #25,040 of 49,997 tracked US assignees by granted-patent volume, with 11 patents across 8 technology areas.

#25,040
of 49,997 US assignees by volume
Top 45%
by Innovation Score (36.8/100)
15.6
avg claims per patent
+20%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R25040 · US Corporation #25,040 · 11 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-RICH · TYPE-USCORP · VEL-UP · BOOK-FULL

  • GRANTS-MICRO 11 grants
  • MID-PACK #25,040/49,997
  • PHOTO-FINISH Pacbrake
  • CPC-NARROW A61N · 8 areas
  • INNOV-THIN 36.8/100
  • CLAIMS-RICH 15.6 claims/avg
  • TYPE-USCORP US Corporation
  • VEL-UP +20% vel
  • BOOK-FULL 10/10 fields

Nearest grant-volume peer: Pacbrake Company (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Pulse’s 36.8 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Innovation-score neighbourhood around Pulse

Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.

score

What this shows Pulse's Innovation Score is 36.8/100 (top 45% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Source USPTO PatentsView, PlainPatent Innovation Score As of 2015–2025

Does more volume mean deeper claims for Pulse?

Each dot is one of Pulse’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Pulse’s own 15.6 claims/patent is ABOVE the 14.8 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Pulse vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView. 2×2 strategic matrix plotting 9 entities by Granted patents (volume) (X) and Avg claims / patent (Y), with a crosshair dividing the plot into four quadrants. Volume + depthSelective & thoroughVolume over depthLean filer 10.910.91111.1 0510152025 Granted patents (volume) Avg claims / patent PTC Therapeutics MP, Inc. - 11, 15.55PTC Therapeutics…PUC Perfect Union Co., Ltd. - 11, 1.45PUC Perfect UnionPulmair Medical, Inc. - 11, 9.09Pulmair MedicalPulsar S.R.L. - 11, 20.82Pulsar S R LPacbrake Company - 11, 20.82PacbrakePacific Consolidated Industries, LLC - 11, 14.82Pacific Consolida…Packaging Technologies & Inspection, LLC - 11, 17.45Packaging & Inspe…Pandion Operations, Inc. - 11, 13.91Pandion OperationsPulse, LLC - 11, 15.55Pulse
Pulse vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Pulse's grants concentrate

Pulse, LLC is a focused PatentsView assignee: 8 CPC subclasses with 63.6% of grants classified under A61N (ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy). Peak complete grant year is 2016 (3 grants) versus a trough of 1 in 2017. By volume, Pulse sits between PTC Therapeutics MP, Inc. and Pandion Operations, Inc..

Pulse's three-year grant acceleration

Pulse, LLC shows 4 grants in 2022–2024 against only 3 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Who files at Pulse's volume?

Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀

patents

What this shows Pulse holds 11 patents at rank #24,980, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Source USPTO PatentsView, granted utility patents As of 2015–2025

Companies ranked near Pulse

By rank, the assignees closest to #24,980 in granted patent volume.

Leaders in A61N (Electrotherapy)

Other assignees with the most granted patents in Pulse's primary technology class.

Pulse's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

37 Top 45% higher than 55% of 49,997 US assignees

This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

0.511.522.533.5 20162017201920202021202220232024 1
USPTO utility patent grants by year · 2016–2024

Grants by year

Teal-shaded recent years (2020–present) versus the 2016–2019 baseline. Full figures in the table below.

View data table
Pulse, LLC patent grants by year, 2015–2025
Year Patents Granted Share of Period
2016 3 27.3%
2017 1 9.1%
2019 1 9.1%
2020 1 9.1%
2021 1 9.1%
2022 1 9.1%
2023 2 18.2%
2024 1 9.1%

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

What to do with this data

Pulse, LLC's patent record in context - here's where to go next.

  • Pulse, LLC's lead technology class is A61N (ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy), 63.6% of its portfolio - see every assignee active in that class. Explore A61N
  • Ranked #25,040 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
  • Compare Pulse, LLC against PTC Therapeutics MP, Inc., an assignee filing at a similar volume. Compare portfolios
  • Innovation Score of 36.8/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.